Mechanism of action at cellular and tissue levels
The pharmacological action of somatropin is based on the precise reproduction of physiological processes characteristic of natural growth hormone. Being a recombinant analogue, the drug has an identical amino acid sequence, allowing it to seamlessly integrate into endocrine regulation.
The mechanism of action of the drug unfolds in several consecutive stages:
- Cellular level: Following administration, the drug molecules reach target cells and interact with specific receptors on their surface. This binding acts as a trigger that leads to the activation of intracellular enzyme systems, specifically mitogen-activated protein kinase.
- Tissue level: Under the influence of activated intracellular cascades, peripheral tissues begin to actively synthesize somatomedins.
- Effector level: Among all somatomedins, insulin-like growth factor (IGF) plays a key role. In modern pharmacology, IGF is considered the primary mediator through which the ultimate anabolic effect of the drug is realized. The hormone itself acts merely as an initiator, while IGF performs all the main work of stimulating cell division.
Pharmacodynamic effects and impact on metabolism
The drug's effect on the body is systemic in nature and affects fundamental metabolic processes. The main pharmacodynamic effect consists of a pronounced enhancement of tissue growth. Bone and muscle tissues are the most sensitive to the drug's action, responding with an active increase in mass and linear dimensions.
To support such intensive growth, the drug radically reorganizes metabolism, directing it toward constructive pathways:
- Protein metabolism: Powerful activation of protein synthesis occurs. This is a classic manifestation of the anabolic action necessary for the formation of new cellular structures.
- Mineral metabolism: The drug promotes the retention of critically important macronutrients in the body. The urinary excretion of phosphorus and calcium, which are necessary for the mineralization of growing bone tissue, is reduced.
- Nitrogen balance: A pronounced nitrogen retention is observed, which is a direct marker of the predominance of protein synthesis processes over breakdown.
- Water-electrolyte balance: The drug decreases sodium excretion, which contributes to fluid retention in the body.
Clinical application and safety profile
The primary target for the therapeutic use of somatropin is dwarfism. The drug is successfully used to correct physical developmental delays, including complex genetic pathologies such as Turner syndrome.
Despite its high clinical efficacy, the use of recombinant growth hormone is associated with a number of side effects that logically stem from its pharmacodynamics:
- Carbohydrate metabolism: The drug exhibits a pronounced counter-regulatory (anti-insulin) action. Opposing the effects of insulin, it can cause hyperglycemia (elevated blood glucose levels).
- Fluid retention: Due to decreased urinary sodium excretion, patients frequently develop edema.
- General symptoms: Non-specific reactions such as headache and pronounced weakness may occur during therapy.
Particular attention in clinical practice is paid to contraindications. Somatropin is strictly contraindicated in patients with malignant neoplasms. Since the drug and its mediator IGF are potent stimulators of cell division, there is a critical risk of stimulating the growth of an existing tumor.
Other anterior pituitary hormones
In addition to growth hormone, the anterior pituitary secretes several other important regulators. The pharmaceutical industry produces thyrotropin (TSH) and prolactin (lactotropic hormone) preparations. However, unlike somatropin, these medicinal products have extremely narrow indications and are not widely used in modern medical practice.
Briefly: answers to topical questions
What is the mechanism of action of somatropin at the intracellular level?
At the intracellular level, the mechanism of action of somatropin involves interaction with specific receptors followed by the activation of mitogen-activated protein kinase.
Somatropin also acts on peripheral tissues, stimulating the production of somatomedins—insulin-like growth factors (IGF). IGF is the main mediator of the anabolic action.
What are the indications for prescribing somatropin?
Indications for prescribing somatropin include various forms of growth retardation. These include:
- Growth hormone deficiency — pituitary dwarfism and hypopituitarism (replacement hormone therapy is performed).
- Dwarfism — including syndromic growth retardation (e.g., in Shereshevsky-Turner syndrome).
At the same time, it is important to consider that growth-promoting therapy is ineffective in chondrodysplasias due to cartilage tissue resistance.
What side effects does somatropin cause?
Somatropin can cause a number of adverse reactions affecting metabolism and the patient's general condition. According to the drug's clinical profile, its main side effects include:
- Edema;
- Weakness;
- Headache;
- Hyperglycemia (this effect is due to the counter-regulatory action of the hormone).
What are the absolute contraindications to the use of somatropin?
A contraindication to the use of somatropin is malignant neoplasms, as there is a risk of stimulating tumor growth.
This is indicated as a contraindication in the sources; no additional absolute contraindications are listed.
Which anterior pituitary hormone preparations are used in medical practice?
Somatropin—a recombinant analogue of human growth hormone—is used in medical practice.
Preparations of other anterior pituitary hormones also exist:
- thyrotropin (TSH);
- prolactin, or lactotropic hormone.
However, thyrotropin and prolactin are not used in widespread medical practice.
For quick memorization of somatropin's effects, use the rule "GROWTH": G — Growth of bones and muscles, R — Retention of fluids (edema due to sodium retention), O — Output of protein synthesis enhanced (and nitrogen retention), W — Working against insulin (hyperglycemia), T — Tumors contraindicated.
Class and exam questions
How does somatropin exert its anabolic effect?
The drug does not act directly, but stimulates the production of somatomedins in peripheral tissues. Insulin-like growth factor (IGF) acts as the main mediator of the anabolic action.
Why can edema occur during drug administration?
Somatropin causes sodium retention in the body and decreases its urinary excretion. This inevitably leads to fluid retention in tissues and the formation of edema.
How does the drug affect blood glucose levels?
Somatropin exhibits counter-regulatory action, meaning it acts as a physiological antagonist of insulin. Because of this, hyperglycemia is one of the frequent side effects of therapy.
In what cases is the prescription of somatropin strictly contraindicated?
The drug is strictly prohibited in the presence of malignant neoplasms. As a potent stimulator of cell division, it carries a high risk of accelerating tumor growth.
What else to study on this topic
- Biochemical cascade of mitogen-activated protein kinase activation upon HGH binding to its receptor.
- The role of insulin-like growth factor (IGF) in the regulation of the cell cycle and anabolism.
- Pathogenesis of Turner syndrome and the clinical rationale for using growth hormone in this pathology.
- Mechanisms of the counter-regulatory action of growth hormone at the tissue level.
- Comparative characteristics of thyrotropin and prolactin preparations: reasons for limited use in practice.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Somatropin" and 5,304 other pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Hormone preparations, their synthetic substitutes, and antagonists"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.